PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

ViiV Healthcare Presents Results of GSK3640254 (GSK'254) in P-IIa study for the Treatment of HIV at CROI

ViiV Healthcare Presents Results of GSK3640254 (GSK'254) in P-IIa study for the Treatment of HIV at CROI

March 10, 2021

Sorrento Collaborates with Mount Sinai to Develop Ab Combination for Neutralizing SARS-CoV-2 and other Emerging Variants of COVID-19

Sorrento Collaborates with Mount Sinai to Develop Ab Combination for Neutralizing SARS-CoV-2 and other Emerging Variants of COVID-...

March 10, 2021

SMA Foundation Collaborates with PTC to Discover and Develop Regenerative Medicine

SMA Foundation Collaborates with PTC to Discover and Develop Regenerative Medicine

March 10, 2021

Gilead Present Results of Lenacapavir in P-II/III CAPELLA Trial for the Treatment of HIV at CROI

Gilead Present Results of Lenacapavir in P-II/III CAPELLA Trial for the Treatment of HIV at CROI

March 10, 2021

AVEO Oncology's Fotivda (tivozanib) Receives the US FDA's Approval for the Treatment of R/R Advanced Renal Cell Carcinoma

AVEO Oncology's Fotivda (tivozanib) Receives the US FDA's Approval for the Treatment of R/R Advanced Renal Cell Carcinoma

March 10, 2021

Takeda to Acquire Maverick for ~$525M

Takeda to Acquire Maverick for ~$525M

March 10, 2021

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us